Starling Oncology (STLNW) Free Cash Flow Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Free Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 57.65% |
| 2 | RadNet | 5.50 Bn | 4.77 Bn | 88.08 Mn | 22.46% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 14.00% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 89.29% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | -81.79% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.75 Bn | - | -14.19% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | -12.01% |
| 8 | Surgery Partners | 1.85 Bn | 1.63 Bn | 622.10 Mn | -35.23% |
| 9 | U S Physical Therapy | 1.18 Bn | 1.15 Bn | 41.94 Mn | -8.24% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 196.69% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 196.69% |
| Mar 31, 2026 | 38.73% |
| Dec 31, 2025 | -3.21% |
| Sep 30, 2025 | -1,183.87% |
| Jun 30, 2025 | 34.75% |
| Mar 31, 2025 | 67.77% |
| Dec 31, 2024 | 147.22% |
| Sep 30, 2024 | 113.21% |
| Jun 30, 2024 | -82.20% |
| Mar 31, 2024 | 4.62% |
| Dec 31, 2023 | 70.27% |
| Sep 30, 2023 | 57.20% |
| Jun 30, 2023 | 18.12% |
| Mar 31, 2023 | 3.85% |
| Dec 31, 2022 | 33.93% |
| Sep 30, 2022 | -494.90% |
| Jun 30, 2022 | -55.51% |
| Mar 31, 2022 | -11,501.94% |
| Dec 31, 2021 | -2,499.14% |
| Sep 30, 2021 | -5,127.68% |